Skip to main content

Table 1 Demographic and clinical characteristics of the SLE patients

From: New insights into the role and mechanism of macrophage migration inhibitory factor in steroid-resistant patients with systemic lupus erythematosus

  SS group (n= 40) SR group (n= 22) Pvalue
Sex (male/female) 7/33 4/18 0.83
Age (years) 30.78 ± 11.76 29.45 ± 13.15 0.69
Years since diagnosis 3.09 ± 4.77 2.74 ± 4.14 0.77
SLEDAI before treatment 11.88 ± 4.49 12.91 ± 5.37 0.42
SLEDAI after treatment 7.5 ± 3.92 15.05 ± 5.27 0.00
Cumulative dose of prednisolone (mg) 7,719.78 ± 8,731.89 6,372.41 ± 8,925.94 0.84
  1. Data presented as mean ± standard deviation. SLEDAI, Systemic Lupus Erythematosus Disease Activity Index; SR, steroid resistant; SS, steroid sensitive. P values calculated using Fisher's exact test or the chi-squared test. P < 0.05 was considered significant.